Example: Heart Attack
Clinical Trials Sponsored by Jiangsu HengRui Medicine Co., Ltd.
Total 399 results
-
NCT04446260RecruitingConditions: Advanced Solid Tumors
-
NCT04766463Not yet recruitingConditions: Pain
-
NCT04737850Not yet recruitingConditions: Immune Thrombocytopenia
-
NCT04718740Not yet recruitingConditions: Recurrent Ovarian Cancer
-
NCT04712838Not yet recruitingConditions: Healthy Subjects
-
NCT04699968Not yet recruitingConditions: Non-Small-Cell Lung Cancer
-
NCT04699175RecruitingConditions: Postsurgical Pain Management
-
NCT04694365RecruitingSafety and Pharmacokinetics of Fluzoparib in Healthy Subjects and Those With Impaired Liver FunctionConditions: Hepatic Impairment; Healthy Subjects
-
NCT04691804Not yet recruitingConditions: Metastatic Castration-Resistant Prostate Cancer (mCRPC)
-
NCT04691063Enrolling by invitationConditions: Small-cell Lung Cancer
-
NCT04688008CompletedConditions: Bioavailability Study
-
NCT04680988Not yet recruitingConditions: Recurrent or Metastatic Cervical Cancer
-
NCT04680091RecruitingConditions: Healthy Subjects, Drug-drug Interaction, Pyrotinib
-
NCT04679038Not yet recruitingConditions: Solid Tumor
-
NCT04676035RecruitingConditions: Prostate Cancer Patients
-
NCT04667156Not yet recruitingConditions: Healthy Volunteers
-
NCT04667143Not yet recruitingConditions: Diabetes Mellitus, Type II
-
NCT04664725RecruitingConditions: Prostate Cancer Patients
-
NCT04663282Not yet recruitingConditions: Type 2 Diabetes
-
NCT04650633Not yet recruitingConditions: Squamous Cell Carcinoma of Head and Neck
-
NCT04649723CompletedConditions: Healthy Subjects, Drug-drug Interaction, Pharmacokinetics, SHR1459
-
NCT04639180Not yet recruitingConditions: Hepatocellular Carcinoma (HCC)
-
NCT04631575Not yet recruitingConditions: Hepatic Impairment; Healthy Participants
-
NCT04631549Not yet recruitingConditions: Hepatic Impairment; Healthy Participants
-
NCT04627129CompletedConditions: Healthy Adult Subjects